Protease inhibitor therapy for recessive dystrophic epidermolysis bullosa-Reference-Cited by-同舟云学术

Protease inhibitor therapy for recessive dystrophic epidermolysis bullosa

Published:1988-06 Issue:6 Volume:18 Page:1246-1252
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Ikeda Shigaku,Manabe Motomu,Muramatsu Tsutomu,Takarnori Kenji,Ogawa Hideoki

Publisher

Elsevier BV

Subject

Dermatology

Reference26 articles.

1. Sixteen types of epidermolysis bullosa—on the clinical discrimination, therapy and prenatal diagnosis;Gedde-Dahl;Acta Derm Venereol [Suppl]. (Stockh),1981

2. Diagnosing epidermolysis bullosa;Eady;Br J Dermatol,1983

3. Studies on the pathogenesis of epidermolysis bullosa;Pearson;J Invest Dermatol,1962

4. Ultrastructural studies in epidermolysis bullosa hereditaria. III. Recessive dystrophic type with dermolytic blistering (Hallopeau-Siemens types and Inversa type);Hashimoto;Arch Dermatol Res,1976

5. Human skin collagenase: relation to the pathogenesis of epidermolysis bullosa dystrophica;Eisen;J Invest Dermatol,1969

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms involved in anosmia induced by SARS-CoV-2, with a focus on the transmembrane serine protease TMPRSS2;Archives of Virology;2022-08-08

2. A comprehensive update on the structure and synthesis of potential drug targets for combating the coronavirus pandemic caused by SARS‐CoV‐2;Archiv der Pharmazie;2022-01-17

3. Camostat mesilate inhibits pro-inflammatory cytokine secretion and improves cell viability by regulating MFGE8 and HMGN1 in lipopolysaccharide-stimulated DF-1 chicken embryo fibroblasts;PeerJ;2021-08-26

4. Molecular mechanism of anti-SARS-CoV2 activity of Ashwagandha-derived withanolides;International Journal of Biological Macromolecules;2021-08

5. Novel Coronavirus Disease (COVID-19): An extensive study on evolution, global health, drug targets and vaccines;International Journal of Clinical Virology;2021-07-05